Does EVOLOCUMAB Cause Hypoaesthesia? 558 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 558 reports of Hypoaesthesia have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
558
Reports of Hypoaesthesia with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
0
Deaths
45
Hospitalizations
How Dangerous Is Hypoaesthesia From EVOLOCUMAB?
Of the 558 reports, 45 (8.1%) required hospitalization, and 6 (1.1%) were considered life-threatening.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 558 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which EVOLOCUMAB Alternatives Have Lower Hypoaesthesia Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE